Marco Verwijs Email

Chief Technical Officer . Adipo Therapeutics

Current Roles

Employees:
10
Revenue:
$1.6M
About
Adipo Therapeutics, an Indiana biotechnology company, is developing polymer-based, Notch-inhibiting nanoparticles that are injected directly into adipose (fat) tissue to induce browning, or white-to-beige adipocyte transformation. The goal? Reducing weight and restoring metabolic balance for millions of people living with diabetes.
Adipo Therapeutics Address

null, null
United States
Adipo Therapeutics Email

Past Companies

Aerovate Therapeutics, Inc.Chief Technical Officer
Aerovate Therapeutics, Inc.Senior Vice President CMC
EpizymeVice President, Drug Product, Analytical Development, and Quality Control at Epizyme